In this week's podcast...

It was a very strong week for the US last week with the S&P 500 Index up 3%. This was driven by the consumer discretionary (or non-essential goods and services) sector, prompted by really strong performance for Amazon.

China‘s gross domestic product (GDP) shrank by 6.8% in the first three months of 2020 as closures due to the coronavirus hit the world’s second largest economy.

The next big focus for the market this week is going to be on a company called Gilead. This company has an Ebola antiviral drug called Remdesivir and they’ve been carrying out some tests on patients with Covid-19.